There have been data suggesting that the anti-inflammatory effect of TGF-β on Th1 and Th2 production and differentiation in macrophages and dendritic cells is a key issue in the skin manifestations of SM [21,27,31-38]. The gene discussed is TGFB1; the disease is systemic mastocytosis.